RACE AND THERAPEUTIC DRUG RESPONSE

被引:25
作者
KALOW, W
机构
关键词
D O I
10.1056/NEJM198903023200909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:588 / 590
页数:3
相关论文
共 11 条
[1]  
AGARWAL DP, 1986, ETHNIC DIFFERENCES R, P99
[2]  
FREIS ED, 1986, ETHNIC DIFFERENCES R, P313
[3]  
KALOW W, 1984, FED PROC, V43, P2314
[4]  
Kalow W., 1986, ETHNIC DIFFERENCES R
[5]   COMPARISON OF ALPRAZOLAM PLASMA-LEVELS IN NORMAL ASIAN AND CAUCASIAN MALE-VOLUNTEERS [J].
LIN, KM ;
LAU, JK ;
SMITH, R ;
PHILLIPS, P ;
ANTAL, E ;
POLAND, RE .
PSYCHOPHARMACOLOGY, 1988, 96 (03) :365-369
[6]   POLYMORPHIC ABILITY TO METABOLIZE PROPRANOLOL ALTERS 4-HYDROXYPROPRANOLOL LEVELS BUT NOT BETA-BLOCKADE [J].
RAGHURAM, TC ;
KOSHAKJI, RP ;
WILKINSON, GR ;
WOOD, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (01) :51-56
[7]   STEADY-STATE RELATIVE BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL PROPRANOLOL IN BLACK AND WHITE NORTH AMERICANS [J].
SHAROKY, M ;
PERKAL, M ;
TURNER, R ;
LESKO, LJ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (05) :447-456
[8]   2 MUTANT ALLELES OF THE HUMAN CYTOCHROME-P-450DB1 GENE (P450C2D1) ASSOCIATED WITH GENETICALLY DEFICIENT METABOLISM OF DEBRISOQUINE AND OTHER DRUGS [J].
SKODA, RC ;
GONZALEZ, FJ ;
DEMIERRE, A ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5240-5243
[9]   BIOLOGIC DETERMINANTS OF PROPRANOLOL DISPOSITION - RESULTS FROM 1308 PATIENTS IN THE BETA-BLOCKER HEART-ATTACK TRIAL [J].
WALLE, T ;
BYINGTON, RP ;
FURBERG, CD ;
MCINTYRE, KM ;
VOKONAS, PS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :509-518
[10]   RACIAL-DIFFERENCES IN DRUG RESPONSE - ALTERED SENSITIVITY TO AND CLEARANCE OF PROPRANOLOL IN MEN OF CHINESE DESCENT AS COMPARED WITH AMERICAN WHITES [J].
ZHOU, HH ;
KOSHAKJI, RP ;
SILBERSTEIN, DJ ;
WILKINSON, GR ;
WOOD, AJJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (09) :565-570